Fig. 4From: In vitro anticancer activity of folate-modified docetaxel-loaded PLGA nanoparticles against drug-sensitive and multidrug-resistant cancer cellsSurvival of cancer cells and human fibroblasts after 72-h exposure to docetaxel, F–NP–Doc and non-targeted docetaxel-loaded PLGA nanoparticles NP–Doc. a HeLa, b LECH, c MCF7, d MCF7R. Cell survival was measured by the MTT assayBack to article page